Orange Book product · Brand (NDA)
CLOLAR
CLOFARABINE
At a glance
Dec 28, 2004
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 28, 2004
21 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
CLOFARABINE
Strength
20MG/20ML (1MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 021673
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025CLOFARABINEGeneric (ANDA)
ANDA 216233 · SCINOPHARM TAIWAN
- 2022CLOFARABINEGeneric (ANDA)
ANDA 212457 · EUGIA PHARMA
- 2020CLOFARABINEGeneric (ANDA)
ANDA 213461 · MEITHEAL
- 2019CLOFARABINEGeneric (ANDA)
ANDA 212034 · ACCORD HLTHCARE
- 2018CLOFARABINEGeneric (ANDA)
ANDA 210283 · HOSPIRA
- 2018CLOFARABINEGeneric (ANDA)
ANDA 207831 · GLAND
- 2018CLOFARABINEGeneric (ANDA)
ANDA 210270 · INGENUS PHARMS LLC
- 2017CLOFARABINEGeneric (ANDA)
ANDA 209775 · MSN
- 2017CLOFARABINEGeneric (ANDA)
ANDA 208857 · AMNEAL
- 2017CLOFARABINEGeneric (ANDA)
ANDA 205375 · DR REDDYS
- 2017CLOFARABINEGeneric (ANDA)
ANDA 208860 · PHARMOBEDIENT
- 2017CLOFARABINEGeneric (ANDA)
ANDA 204029 · ABON PHARMS LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
